By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
India Times NowIndia Times NowIndia Times Now
Notification Show More
Font ResizerAa
  • Bharat Shreshtha Ratna Sanman
  • India News
  • Categories
    • Technology
    • Entertainment
    • The Escapist
    • Insider
    • Finance ₹
    • India News
    • Science
    • Health
Reading: Pharma stock under Rs 50 ends session in red, shares update on proposed acquisition of US-based firm
Share
India Times NowIndia Times Now
Font ResizerAa
  • Bharat Shreshtha Ratna Sanman
  • India News
  • Categories
Search
  • Bharat Shreshtha Ratna Sanman
  • India News
  • Categories
    • Technology
    • Entertainment
    • The Escapist
    • Insider
    • Finance ₹
    • India News
    • Science
    • Health
Have an existing account? Sign In
Follow US

Home » Pharma stock under Rs 50 ends session in red, shares update on proposed acquisition of US-based firm

BusinessStartup

Pharma stock under Rs 50 ends session in red, shares update on proposed acquisition of US-based firm

India Times Now Desk
Last updated: September 15, 2026 12:15 pm
India Times Now Desk
Published: September 15, 2026
Share
SHARE


Shares of Sudarshan Pharma Industries ended the trading session in the red at Rs 39 with a decline of Rs 0.45 or 1.14 per cent from the previous close of Rs 29.45 on the BSE. The market cap of the company stood at Rs 973.67 crore. The stock started the trading session in the green amid positive openings in the benchmark indices but tumbled amid selling pressure. The counter opened at Rs 39.85, up Rs 0.40, or 1.01 per cent. During the day, it touched the intraday high of Rs 41.24 and an intraday low of Rs 39. Meanwhile, the Mumbai-headquartered pharmaceutical company clarified the current status of the deal and said that the transaction is awaiting formal confirmation and a board resolution from Med Therapy’s board of directors.

Acquisition proposal under due diligence

The company said the proposal to acquire 9.50 per cent equity shares in Med Therapy Biotechnology Inc. (Med Therapy) of the US is currently under due diligence. Therefore, the company has provided only this information for now and said it will issue an update soon.

Similarly, proposals by the Company’s promoters and directors, Chairman and Managing Director Hemal Mehta and Joint Managing Director Sachin Mehta, to acquire 1.50% equity shares each in Med Therapy are also undergoing due diligence and board approval. These proposals are also pending final confirmation.

Stock market today

Meanwhile, benchmark Sensex tanked 778 points while the broader stock index Nifty closed at a five-month low on Tuesday amid surging oil prices, geopolitical tensions and weak trends in global markets.

The 30-share BSE Sensex tumbled 777.94 points, or 1.04 per cent, to settle at a three-month low of 74,003.82, dragged by losses in blue-chip banking, auto and oil & gas shares. The index opened higher but lost steam in late-morning deals as selling gathered pace. The barometer later tanked 787.73 points, or 1.05 per cent, to a day’s low of 73,994.03.

The 50-share NSE Nifty dropped 279.50 points, or 1.19 per cent, to end at 23,118.60, the lowest closing level since April 6. Domestic equity markets were closed on Monday for Ganesh Chaturthi.

ALSO READ:

Raymond shares details of its aerospace subsidiary, stock jumps 35% per cent in 1 week

(This article is for informational purposes only and should not be construed as investment, financial, or other advice.)





Source link

Gamechanger! 30-km expressway to Jewar Airport promises faster Delhi–Noida travel – Details
Gold witnesses mild gain on MCX, silver drops to Rs 2.43 lakh per kg amid Middle East tensions | Check city-wise rates
DA Allowance: Cabinet approves DA hike for central govt employees and pensioners, say sources
From Duroflex to Virupaksha Organics, these companies get SEBI nod to launch IPO
India buys 2.5 billion euro of Russian oil in October ahead of new sanctions
TAGGED:acquisitionendsfirmMed Therapy Biotechnologypharmaproposedredsessionsharesstockstock in focusstock marketSudarshan PharmaSudarshan Pharma share priceupdateUSbased
Share This Article
Facebook Email Print
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe
TelegramFollow

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
[mc4wp_form]
Popular News
BusinessStartup

Defence stock under Rs 400 gains after being declared lowest bidder for DRDO project – Details

India Times Now Desk
India Times Now Desk
October 16, 2025
West Bengal Assembly polls: Matua first family split deepens battle in Bagda, Gaighata as SIR jolts BJP bastions
In Punjab, open wounds from hit jobs on Ambedkar statues
House Committee of the Lok Sabha is yet to be reconstituted
The Malleshwaram police registered a case on February 19 against a dermatologist for allegedly spreading misinformation about Nandini products online.
- Advertisement -
Ad imageAd image
Global Coronavirus Cases

Confirmed

0

Death

0

More Information:Covid-19 Statistics
© INDIA TIMES NOW 2026 . All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?